Home » Health » COVID-19 Strain XBB.1.9.2* Found in 24.5% of Cases, WHO Issues 2024 Vaccine Criteria

COVID-19 Strain XBB.1.9.2* Found in 24.5% of Cases, WHO Issues 2024 Vaccine Criteria

Hamburger

16 Dec. 2023 11:15 a.m.

Share news

column

Dr. Yongyot Thamwut, Acting Director-General of the Department of Medical Sciences, revealed that COVID-19 strain data dated 1 Oct. – 2 Dec. 2023 from genetic decoding of 253 people found the XBB.1.9 strain. .2* has the largest proportion, accounting for 24.5%. Next is EG.5*, accounting for 23.3%, both of which the aforementioned two species are likely to increase. while strains XBB.1.16* and XBB.2.3* tended to decrease. Compared to the previous 2 months As for the species XBB.1.16* “Arcturus”, inspection in September-November 2023. The XBB.1.16* strain was found in 83 people, or 16.4%. Most of the patients, 90%, had symptoms of fever, cough, sore throat, mucus, phlegm, aches and pains. Some, about 10%, had symptoms of fatigue. Tired/panting as well There were no symptoms of red eyes, rashes, or runny noses. as information is forwarded on social media

Dr. Chakkrat Pittayawonganon, M.D. Director of the Epidemiology Division, Department of Disease Control, said that the World Health Organization (WHO) has issued criteria for receiving the COVID-19 vaccine in 2024, with 608 groups receiving one dose per year, including those with low immune systems, such as people with organ transplants or dialysis. You must receive 2 shots of the vaccine every 6 months. For the general public, there is no need to receive the vaccine. But the injection can be done voluntarily and you must pay for the service yourself. According to a survey of at-risk groups who need to receive the COVID-19 vaccine, there are 15 million people, while there are 600,000 doses of COVID vaccine remaining. Whether or not to order more vaccines depends on Must wait for the Department of Disease Control to consider Initially, as far as surveying the demand for vaccines in high-risk groups, it was found that there was only 10% for vaccines around the world. Currently, only Pfizer’s m-RNA type remains in production. As for the situation in Thailand, it is expected that within 3-4 weeks the number of people infected with COVID-19 will increase. It will gradually rise, surpassing that of influenza. Most are of working age and believe that the symptoms are not severe. But don’t be close to the elderly only.

divmargin:0 -15px;@media (max-width:767.98px).css-x9zhmpwidth:100vw;max-width:inherit;margin:30px -15px;]]>
2023-12-16 04:15:09

#Advise #group #COVID #vaccine #year

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.